Sonova Holding (OTCMKTS:SONVY) Given Average Recommendation of “Hold” by Analysts

Shares of Sonova Holding (OTCMKTS:SONVY) have been assigned an average recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating on the company.

Several research analysts have commented on SONVY shares. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a report on Tuesday, June 23rd. UBS Group raised Sonova from a “neutral” rating to a “buy” rating in a research report on Wednesday. Finally, Citigroup restated a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th.

Sonova Price Performance

Shares of OTCMKTS:SONVY opened at $51.87 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51. The firm’s 50 day simple moving average is $50.22 and its 200-day simple moving average is $49.71. Sonova has a one year low of $42.26 and a one year high of $61.09.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.